We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

ANAVEX2-73 for Treatment of Early Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03790709
Recruitment Status : Completed
First Posted : January 2, 2019
Last Update Posted : July 14, 2022
Anavex Australia Pty Ltd.
Anavex Germany GmbH
Anavex Canada Ltd.
Information provided by (Responsible Party):
Anavex Life Sciences Corp.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 30, 2022
Actual Study Completion Date : June 30, 2022